tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TSE:MDP Stock Latest News

Medexus Pharmaceuticals Hits Record Revenue
Company AnnouncementsMedexus Pharmaceuticals Hits Record Revenue
30d ago
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Medexus Pharmaceuticals Announces Upcoming Earnings Call
PremiumCompany Announcements
Medexus Pharmaceuticals Announces Upcoming Earnings Call
1M ago
Medexus Awaits FDA Decision on Treosulfan
PremiumCompany Announcements
Medexus Awaits FDA Decision on Treosulfan
2M ago
Medexus Pharmaceuticals Accepts Metoject® Ruling
PremiumCompany Announcements
Medexus Pharmaceuticals Accepts Metoject® Ruling
3M ago
Medexus Pharmaceuticals Shines at Investor Conference
PremiumCompany AnnouncementsMedexus Pharmaceuticals Shines at Investor Conference
4M ago
Medexus’s Hemophilia B Drug Now Pediatric-Approved
PremiumCompany Announcements
Medexus’s Hemophilia B Drug Now Pediatric-Approved
4M ago
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units
PremiumPress Releases
Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units
11M ago
Is MDP a Buy, Before Earnings?
PremiumPre-Earnings
Is MDP a Buy, Before Earnings?
12M ago
Medexus Pharmaceuticals (MDP) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Medexus Pharmaceuticals (MDP) Q4 Earnings Cheat Sheet
1y ago
Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
PremiumPress Releases
Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
1y ago
Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
PremiumPress ReleasesMedexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
1y ago
Medexus Announces New License Deal for Topical Terbinafine
PremiumPress Releases
Medexus Announces New License Deal for Topical Terbinafine
1y ago
Medexus Announces US$58.5 million in New Credit Facilities
PremiumPress Releases
Medexus Announces US$58.5 million in New Credit Facilities
1y ago
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
PremiumPress Releases
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
1y ago
Medexus Welcomes Two New Board Members
PremiumPress Releases
Medexus Welcomes Two New Board Members
1y ago
Medexus Secures Public Reimbursement for Cuvposa® in Quebec
PremiumPress Releases
Medexus Secures Public Reimbursement for Cuvposa® in Quebec
1y ago
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
PremiumPress Releases
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
1y ago
Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
PremiumPress ReleasesMedexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
2y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >